FDA consumer warning
This article was originally published in The Tan Sheet
Executive Summary
The dietary supplements Emagrece Sim and Herbathin should not be used and should be returned to suppliers because they "may contain several active ingredients, including controlled substances, found in prescription drugs that could lead to serious side effects or injury," the agency announces Jan. 13. FDA has issued an import alert to prevent importation of the products, which are made in Brazil by the firms Fitoterapicos and Phytotherm Sim. The products contain fluoxetine HCl (Prozac) and chlordiazepoxide HCl (Librium), which are used to relieve anxiety, according to FDA. They also were found to contain Fenproporex, a stimulant that is "not approved for marketing in the U.S." and is converted in the body to amphetamine. The supplements are sold on the Internet, and FDA is "aware of commercial imports of these products and individuals importing them for personal use"...
You may also be interested in...
Recent And Upcoming FDA Advisory Committee Meetings
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
International Harmonization: Not Just For Audits Anymore
The International Medical Device Regulators Forum, perhaps most notorious for its efforts to standardize audit processes between nations with its Medical Device Single Audit Program, is also focusing on harmonizing device reviews and adverse event codes.
Reddy’s Settles On $7bn Revlimid But Natco Maintains The Lead
Dr Reddy’s Laboratories has become the third Revlimid ANDA sponsor to settle patent litigation action with Bristol Myers Squibb’s Celgene. However, the Indian company will join Alvogen in not being able to launch before first settler Natco, which has partnered with Teva’s Watson.
Need a specific report? 1000+ reports available Buy Reports
Register for our free email digests: